GLP-1 Drug Exendin-4 Protects Dopamine Neurons From Parkinson's-Like Damage
The GLP-1 receptor agonist exendin-4 protected dopaminergic neurons by inhibiting microglial activation and MMP-3 expression, establishing a neuroprotective role for incretin drugs in Parkinson's-like neurodegeneration.
Quick Facts
What This Study Found
The GLP-1 receptor agonist exendin-4 protected dopaminergic neurons by inhibiting microglial activation and MMP-3 expression, establishing a neuroprotective role for incretin drugs in Parkinson's-like neurodegeneration.
Key Numbers
How They Did This
research study.
Why This Research Matters
Relevant for peptide research.
The Bigger Picture
Advances peptide research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
Trust & Context
- Key Stat:
- Key finding The GLP-1 receptor agonist exendin-4 protected dopaminergic neurons by inhibiting microglial activation and MMP-3 expression, establishing a neuroprot
- Evidence Grade:
- emerging evidence.
- Study Age:
- Published in 2009.
- Original Title:
- Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease.
- Published In:
- The Journal of endocrinology, 202(3), 431-9 (2009)
- Authors:
- Kim, Sehee, Moon, Minho, Park, Seungjoon(2)
- Database ID:
- RPEP-01505
Evidence Hierarchy
Frequently Asked Questions
What was studied?
GLP-1 Drug Exendin-4 Protects Dopamine Neurons From Parkinson's-Like Damage
What was found?
The GLP-1 receptor agonist exendin-4 protected dopaminergic neurons by inhibiting microglial activation and MMP-3 expression, establishing a neuroprotective role for incretin drugs in Parkinson's-like neurodegeneration.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01505APA
Kim, Sehee; Moon, Minho; Park, Seungjoon. (2009). Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease.. The Journal of endocrinology, 202(3), 431-9. https://doi.org/10.1677/JOE-09-0132
MLA
Kim, Sehee, et al. "Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease.." The Journal of endocrinology, 2009. https://doi.org/10.1677/JOE-09-0132
RethinkPeptides
RethinkPeptides Research Database. "Exendin-4 protects dopaminergic neurons by inhibition of mic..." RPEP-01505. Retrieved from https://rethinkpeptides.com/research/kim-2009-exendin4-protects-dopaminergic-neurons
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.